ICON Public Limited Company (ICLR)Healthcare | Diagnostics & Research | Dublin, Ireland | NasdaqGS
175.13 USD
+6.16
(3.646%)
⇧
(Oct. 15, 2026, 4 p.m.
EDT)
|
Hot Take ↕ | Oct. 10, 2026, 10:28 a.m. EDT
ICON presents a precarious investment case where speculative optimism clashes with deteriorating fundamentals. The company is trading at a trailing P/E of 173 times despite reporting a 63 percent collapse in quarterly earnings growth and a negligible 0.3 percent profit margin, signaling severe operational distress. While the forward P/E of 14 times hints at a potential earnings recovery, the balance sheet is fragile with a debt-to-equity ratio of 37.6 times and a current ratio below one. Technically, the stock holds above its 200-day moving average, offering some support, but the heavy put option positioning for late 2026 warns of lingering downside risk. Without a proven turnaround in profitability and a strengthening balance sheet, the current valuation lacks a safety margin, making this a risky speculative hold rather than a core investment. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.026334 |
| AutoETS | 0.029049 |
| AutoTheta | 0.133953 |
| AutoARIMA | 0.232289 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 46% |
| H-stat | 0.53 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.838 |
| Excess Kurtosis | 0.03 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 37.596 |
| Revenue per Share | 107.957 |
| Market Cap | 13,512,016,896 |
| Trailing P/E | 184.35 |
| Forward P/E | 14.86 |
| Beta | 1.24 |
| Profit Margins | 0.33% |
| Website | https://www.iconplc.com |
As of Oct. 10, 2026, 10:28 a.m. EDT: Speculators are positioning defensively for late 2026, evidenced by a massive open interest skew toward out-of-the-money puts (660 contracts versus only 11 in-the-money puts for the December expiration). While call activity clusters near current levels with a notable wall at the 175 strike, the implied volatility remains elevated, suggesting uncertainty. The heavy put positioning indicates a fear of a significant downside move over the coming months.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.053658247 |
| Address1 | South County Business Park |
| Address2 | Leopardstown |
| All Time High | 347.72 |
| All Time Low | 2.5 |
| Ask | 214.91 |
| Ask Size | 2 |
| Average Analyst Rating | 1.9 - Buy |
| Average Daily Volume10 Day | 825,070 |
| Average Daily Volume3 Month | 846,354 |
| Average Volume | 846,354 |
| Average Volume10Days | 825,070 |
| Beta | 1.24 |
| Bid | 172.6 |
| Bid Size | 1 |
| Book Value | 121.551 |
| City | Dublin |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | Ireland |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 175.13 |
| Current Ratio | 0.953 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 177.195 |
| Day Low | 166.94 |
| Debt To Equity | 37.596 |
| Display Name | ICON |
| Dividend Yield | 0.0 |
| Earnings Call Timestamp End | 1,793,217,600 |
| Earnings Call Timestamp Start | 1,793,217,600 |
| Earnings Growth | -0.633 |
| Earnings Quarterly Growth | -0.643 |
| Earnings Timestamp | 1,793,131,200 |
| Earnings Timestamp End | 1,793,131,200 |
| Earnings Timestamp Start | 1,793,131,200 |
| Ebitda | 523,480,992 |
| Ebitda Margins | 0.06311 |
| Enterprise To Ebitda | 30.774 |
| Enterprise To Revenue | 1.942 |
| Enterprise Value | 16,109,466,624 |
| Eps Current Year | 10.5745 |
| Eps Forward | 11.78355 |
| Eps Trailing Twelve Months | 0.95 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 353 1 247 6260 |
| Fifty Day Average | 167.2098 |
| Fifty Day Average Change | 7.920212 |
| Fifty Day Average Change Percent | 0.047366913 |
| Fifty Two Week Change Percent | -5.3658247 |
| Fifty Two Week High | 203.91 |
| Fifty Two Week High Change | -28.779999 |
| Fifty Two Week High Change Percent | -0.14114068 |
| Fifty Two Week Low | 66.57 |
| Fifty Two Week Low Change | 108.560005 |
| Fifty Two Week Low Change Percent | 1.6307647 |
| Fifty Two Week Range | 66.57 - 203.91 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 895,239,000,000 |
| Float Shares | 77,097,886 |
| Forward Eps | 11.78355 |
| Forward P E | 14.862245 |
| Free Cashflow | 622,646,656 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 40,200 |
| Fullday Change | 6.1600037 |
| Fullday Change Percent | 3.6456196 |
| Fullday Price | 175.13 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.23909001 |
| Gross Profits | 1,983,081,984 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.00446 |
| Held Percent Institutions | 1.07958 |
| Implied Shares Outstanding | 77,154,209 |
| Industry | Diagnostics & Research |
| Industry Disp | Diagnostics & Research |
| Industry Key | diagnostics-research |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,218,585,600 |
| Last Split Factor | 2:1 |
| Long Business Summary | ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, contract staffing, data solutions, and laboratory services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers testing services comprising bioanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, medical imaging, real world intelligence, site and patient, and strategic solutions. Additionally, it provides therapeutics for cardiovascular, central nervous system, endocrine and metabolic disorders, hepatology, infectious diseases, internal medicine immunology, and oncology. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland. |
| Long Name | ICON Public Limited Company |
| Market | us_market |
| Market Cap | 13,512,016,896 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_397809 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | 27,043,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 12,645,574,855 |
| Number Of Analyst Opinions | 17 |
| Open | 170.2 |
| Operating Cashflow | 1,112,029,056 |
| Operating Margins | 0.094119996 |
| Payout Ratio | 0.0 |
| Peg Ratio | 0.51 |
| Phone | 353 1 291 2000 |
| Previous Close | 168.97 |
| Price Eps Current Year | 16.56154 |
| Price Hint | 2 |
| Price To Book | 1.4407945 |
| Price To Sales Trailing12 Months | 1.6290497 |
| Profit Margins | 0.0032600001 |
| Quick Ratio | 0.924 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 1.94444 |
| Region | US |
| Regular Market Change | 6.16 |
| Regular Market Change Percent | 3.64562 |
| Regular Market Day High | 177.195 |
| Regular Market Day Low | 166.94 |
| Regular Market Day Range | 166.94 - 177.195 |
| Regular Market Open | 170.2 |
| Regular Market Previous Close | 168.97 |
| Regular Market Price | 175.13 |
| Regular Market Time | 1,792,094,401 |
| Regular Market Volume | 767,361 |
| Return On Assets | 0.00969 |
| Return On Equity | 0.0028600001 |
| Revenue Growth | 0.012 |
| Revenue Per Share | 107.957 |
| Sand P52 Week Change | 0.16207206 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 77,154,209 |
| Shares Percent Shares Out | 0.0363 |
| Shares Short | 2,801,170 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 2,379,093 |
| Short Name | ICON plc |
| Short Percent Of Float | 0.040999997 |
| Short Ratio | 2.69 |
| Source Interval | 15 |
| Symbol | ICLR |
| Target High Price | 220.0 |
| Target Low Price | 155.0 |
| Target Mean Price | 187.76471 |
| Target Median Price | 186.0 |
| Total Cash | 928,385,024 |
| Total Cash Per Share | 12.033 |
| Total Debt | 3,525,835,008 |
| Total Revenue | 8,294,416,896 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 0.95 |
| Trailing P E | 184.34738 |
| Trailing Peg Ratio | 0.4979 |
| Triggerable | 1 |
| Two Hundred Day Average | 145.7914 |
| Two Hundred Day Average Change | 29.338608 |
| Two Hundred Day Average Change Percent | 0.20123689 |
| Type Disp | Equity |
| Volume | 767,361 |
| Website | https://www.iconplc.com |
| Zip | D18 X5R3 |